We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Russia, Stelis Biopharma Team Up to Make 200 Million Doses of Sputnik V
Russia, Stelis Biopharma Team Up to Make 200 Million Doses of Sputnik V
The Russian Direct Investment Fund (RDIF) and Indian contract manufacturer Stelis Biopharma have partnered to produce 200 million doses of the Sputnik V COVID-19 vaccine.